Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The Combined Assessment of Function and Survival (CAFS): a new endpoint for ALS clinical trials.

The Combined Assessment of Function and Survival (CAFS): a new endpoint for ALS clinical trials. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Apr; 14(3):162-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.